Xinyu Huang, MBA, is an experienced professional in the biopharma and healthcare sectors, currently serving as a Venture Fellow at TSVC since January 2021, where responsibilities include sourcing and closing investment deals and performing due diligence on healthcare startups. Previously, Xinyu worked as a Strategy Consultant at Health Advances from January 2022 to June 2023, contributing to over ten consulting engagements and developing oncology-focused strategies for clients. Earlier roles include serving as a Senior Associate Scientist at ElevateBio, an Associate Scientist at Intellia Therapeutics, and a Research Associate at Abpro, among others. Xinyu holds an MBA from Boston University, an M.S. in Human Nutrition from Columbia University, and a B.S. in Physiological Science from UCLA.
Upgrade to view 0 reports
This person is not in any teams
This person is not in any offices
TSVC
TSVC is a venture capital firm that focuses on early-stage deep technology startups. TSVC invests in forward-thinking ideas and cutting-edge deep technologies as well as partnering with founders in Silicon Valley’s entrepreneurial community.TSVC delivers outstanding returns to investors by funding over 160 startups in deep tech-focused areas likeSaaS, AI chips, Fintech, Biotech, Blockchain, and Semiconductors. Their mission is to support entrepreneurs with unique insights and solid technical expertise and to bring them distinctive values along with crucial funding to make their ideas into reality. TSVC's investment philosophy centers on the belief that today’s visionaries will make tomorrow’s reality.TSVC was founded in 2010 and is based in Los Altos, California.